On 1 October 2019 the funded brand of lamotrigine changed from Lamictal, Arrow-Lamotrigine and Logem to Logem only.
Lamotrigine is used to treat epilepsy and some mental health conditions, such as bipolar disorder.
Last updated 20 November 2019
Information about generics and biosimilar medicines
Exceptional circumstances for funding alternative brands of lamotrigine [DOC, 192 KB]
Refund of GP co-payment [PDF, 518 KB]
Back to top